BRAF and ganglioglioma: Control cases of gangliogliomas with BRAF V600E (control 1, 2) and NF1 association (control 3) showed strong Cyclin D1 expression (Fig. 4D, F, H) indicating MAPK pathway activation, while there was no nuclear NFκB staining (Fig. 4C, E, G).